- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Chemistry
Volume 2013 (2013), Article ID 840614, 4 pages
The C60(FeCp2)2-Based Cell Proliferation Accelerator
1Laboratory for Superconducting Materials Physics, State Scientific and Production Association “Scientific-Practical Materials Research Center of the NAS of Belarus”, P. Brovka Street 19, 220072 Minsk, Belarus
2Department of New Materials, Lykov Institute of the Heat and Mass Transfer of the NAS of Belarus, P. Brovka Street 15, 220072 Minsk, Belarus
3Central Scientific Research Laboratory of the Belarus State Medical University, Dzerjinski Avenue, 83, 220116 Minsk, Belarus
4Institute of Physiology of the NAS of Belarus, Academicheskaya Street 28, 220072 Minsk, Belarus
5School of Chemistry, Manchester University, Oxford Road, Manchester M13 9PL, UK
Received 22 February 2013; Accepted 4 April 2013
Academic Editor: Mehmet Senel
Copyright © 2013 Andrei Soldatov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- H. L. Ma and X. J. Liang, “Fullerenes as unique nanopharmaceuticals for disease treatment,” Science China Chemistry, vol. 53, no. 11, pp. 2233–2340, 2010.
- C. A. Theriot, R. C. Casey, V. C. Moore et al., “Dendro[C60]fullerene DF-1 provides radioprotection to radiosensitive mammalian cells,” Radiation and Environmental Biophysics, vol. 49, no. 3, pp. 437–445, 2010.
- R. D. Bolskar, A. F. Benedetto, L. O. Husebo et al., “First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit In vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent,” Journal of the American Chemical Society, vol. 125, no. 18, pp. 5471–5478, 2003.
- S. S. Ali, J. I. Hardt, K. L. Quick et al., “A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties,” Free Radical Biology and Medicine, vol. 37, no. 8, pp. 1191–1202, 2004.
- J. J. Ryan, H. R. Bateman, A. Stover et al., “Fullerene nanomaterials inhibit the allergic response,” Journal of Immunology, vol. 179, no. 1, pp. 665–672, 2007.
- H. Meng, G. Xing, B. Sun et al., “Potent angiogenesis inhibition by the particulate form of fullerene derivatives,” ACS Nano, vol. 4, no. 5, pp. 2773–2783, 2010.
- J. Zhu, Z. Ji, J. Wang et al., “Tumor-inhibitory effect and immunomodulatory activity of fullerol C60(OH)x,” Small, vol. 4, no. 8, pp. 1168–1175, 2008.
- Y. Y. Xu, J. D. Zhu, K. Xiang, Y. K. Li, R. H. Sun, and J. Ma, “Synthesis and immunomodulatory activity of fullerene-tuftsin conjugates,” Biomaterials, vol. 32, no. 36, pp. 9940–9949, 2011.
- H. Tsumoto, S. Kawahara, Y. Fujisawa et al., “Syntheses of water-soluble fullerene derivatives and their enhancing effect on neurite outgrowth in NGF-treated PC12 cells,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 6, pp. 1948–1952, 2010.
- R. Maeda-Mamiya, E. Noiri, H. Isobe et al., “In vivo gene delivery by cationic tetraamino fullerene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 12, pp. 5339–5344, 2010.
- S. Fiorito, A. Serafino, F. Andreola, and P. Bernier, “Effects of fullerenes and single-wall carbon nanotubes on murine and human macrophages,” Carbon, vol. 44, no. 6, pp. 1100–1105, 2006.
- Y. Saitoh, A. Miyanishi, H. Mizuno et al., “Super-highly hydroxylated fullerene derivative protects human keratinocytes from UV-induced cell injuries together with the decreases in intracellular ROS generation and DNA damages,” Journal of Photochemistry and Photobiology B, vol. 102, no. 1, pp. 69–76, 2011.
- S. Yasukazu, M. Hiromi, X. Li, H. Sayuri, K. Ken, and M. Nobuhiko, “Polyhydroxylated fullerene C60(OH)44 suppresses intracellular lipid accumulation together with repression of intracellular superoxide anion radicals and subsequent PPARγ2 expression during spontaneous differentiation of OP9 preadipocytes into adipocytes,” Molecular and Cellular Biochemistry, vol. 366, no. 1-2, pp. 191–1200, 2012.
- P. Kopf-Maier, H. Kopf, and E. W. Neuse, “Ferrocenium salts—the first antitumor iron compounds,” Angewandte Chemie, vol. 96, no. 6, pp. 446–447, 1984.
- P. Kopf-Maier, H. Kopf, and E. W. Neuse, “Ferricenium complexes: a new type of water-soluble antitumor agent,” Journal of Cancer Research and Clinical Oncology, vol. 108, no. 3, pp. 336–340, 1984.
- V. N. Babin, P. M. Raevskii, K. G. Shitkov, L. V. Snegur, and S. Y. Nekrasov, “Antitumor activity of metallocenes,” Mendeleev Chemistry Journal, vol. 39, no. 2, pp. 17–23, 1995.
- A. J. Deeming, “Mononuclear Iron Compounds with η2–η6 Hydrocarbon Ligands,” in Comprehensive organometallic chemistry, G. Wilkinson, F. G. A. Stone, and E. W. Abel, Eds., p. 481, Pergamon Press, 1982.
- N. Guskos, A. G. Soldatov, G. Zolnierkiewicz, V. Likodimos, and S. Glenis, “Spin dynamics and charge transfer in C60-2ferrocene studied by electron spin resonance,” Journal of Non-Crystalline Solids, vol. 354, no. 35-39, pp. 4334–4337, 2008.
- J. D. Crane, P. B. Hitchcock, H. W. Kroto, R. Taylor, and D. R. M. Walton, “Preparation and characterisation of C60(ferrocene)2,” Journal of the Chemical Society, Chemical Communications, no. 24, pp. 1764–1765, 1992.